CD274 and endometrium neoplasm: A recent study evaluated PD-L1 expression in MMR deficient endometrial tumors, either Lynch syndrome associated or sporadic tumors (with MLH1 hypermethylation), and showed a significant higher PD-L1 expression compared to the MMR proficient counterpart [54].